We are live on ! Find out more
ZBH icon

Zimmer Biomet

720 hedge funds and large institutions have $14.4B invested in Zimmer Biomet in 2014 Q3 according to their latest regulatory filings, with 62 funds opening new positions, 222 increasing their positions, 284 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more funds holding in top 10

Funds holding in top 10: 58 (+3)

51% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 41

2% more funds holding

Funds holding: 707720 (+13)

0% less call options, than puts

Call options by funds: $72.2M | Put options by funds: $72.4M

0.43% less ownership

Funds ownership: 88.52%88.1% (-0.43%)

6% less capital invested

Capital invested by funds: $15.3B → $14.4B (-$887M)

22% less repeat investments, than reductions

Existing positions increased: 222 | Existing positions reduced: 284

Holders
720
Holders Change
+13
Holders Change %
+1.84%
% of All Funds
20.89%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.23%
New
62
Increased
222
Reduced
284
Closed
41
Calls
$72.2M
Puts
$72.4M
Net Calls
-$226K
Net Calls Change
-$189M
Name Holding Trade Value Shares
Change
Change in
Stake
CA
226
Commerzbank Aktiengesellschaft
Germany
$5.4M +$1.18M +12,008 +28%
AP
227
AHL Partners
United Kingdom
$5.4M +$5.44M +55,276 New
GH
228
GAM Holding
Switzerland
$5.36M -$524K -5,332 -9%
STCG
229
Speece Thorson Capital Group
Minnesota
$5.26M +$249K +2,534 +5%
WF
230
Welch & Forbes
Massachusetts
$5.12M -$189K -1,921 -4%
Comerica Bank
231
Comerica Bank
Texas
$5.11M -$476K -4,838 -8%
LI
232
LMCG Investments
Massachusetts
$5.09M +$10.5K +107 +0.2%
BCAM
233
Boston Common Asset Management
Massachusetts
$5.07M -$1.36M -13,848 -21%
SM
234
Stratton Management
Pennsylvania
$5.03M -$600K -6,098 -11%
EAM
235
EverPoint Asset Management
Connecticut
$5.03M +$5.07M +51,500 New
GTC
236
Ghost Tree Capital
New York
$5.03M +$5.07M +51,500 New
IHM
237
Iguana Healthcare Management
New York
$5.03M +$5.07M +51,500 New
MSA
238
Mason Street Advisors
Wisconsin
$5.02M +$14.3K +145 +0.3%
GIBU
239
Gulf International Bank (UK)
United Kingdom
$4.83M
ASRS
240
Arizona State Retirement System
Arizona
$4.72M -$70.9K -721 -1%
PAM
241
Paradigm Asset Management
New York
$4.68M -$122K -1,236 -3%
CCM
242
Catawba Capital Management
Virginia
$4.52M -$351K -3,566 -7%
RJA
243
Raymond James & Associates
Florida
$4.47M +$2.16M +21,993 +92%
BACM
244
Blue Arrow Capital Management
New York
$4.43M +$3.46M +35,185 +345%
WBC
245
Westpac Banking Corp
Australia
$4.4M +$547K +5,562 +14%
HIMCH
246
Hartford Investment Management Co (HIMCO)
Connecticut
$4.38M -$144K -1,462 -3%
FAF
247
Fjarde Ap-fonden
Sweden
$4.38M -$369K -3,752 -8%
BCA
248
Bernzott Capital Advisors
California
$4.35M -$484K -4,923 -10%
FMLI
249
Fukoku Mutual Life Insurance
Japan
$4.29M +$172K +1,751 +4%
Mackenzie Financial
250
Mackenzie Financial
Ontario, Canada
$4.28M +$1.94M +19,739 +82%

ZBH Hedge Fund Activity: Q3 2014 in Review

720 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q3 2014, worth a combined $14.4B — down 5.8% from $15.3B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new ZBH positions and 41 closed out — a net gain of 21 holders — while 222 added to existing stakes and 284 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $354M. The largest seller was Caisse de Depot et Placement du Quebec (CDPQ), cutting an estimated $148M.

  • 720 institutional investors held Zimmer Biomet (ZBH) as of Q3 2014, up from 707 in Q2 2014.
  • Funds reported $14.4B of Zimmer Biomet stock for Q3 2014, down 5.8% quarter-over-quarter.
  • 62 funds opened new Zimmer Biomet positions in Q3 2014 and 41 closed out, a net change of +21 holders.
  • The largest Zimmer Biomet buyer in Q3 2014 was Fidelity Investments, an estimated $354M added.
  • The largest Zimmer Biomet seller in Q3 2014 was Caisse de Depot et Placement du Quebec (CDPQ), an estimated $148M sold.

Based on aggregated 13F filings for Q3 2014.